• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于根据药物的体外跨细胞通透性预测鼻腔给药药物吸收的动力学模型。

Kinetic model to predict the absorption of nasally applied drugs from in vitro transcellular permeability of drugs.

作者信息

Furubayashi Tomoyuki, Kamaguchi Akiko, Kawaharada Kazushi, Masaoka Yoshie, Kataoka Makoto, Yamashita Shinji, Higashi Yutaka, Sakane Toshiyasu

机构信息

School of Pharmacy, Shujitsu University, Okayama, Japan.

出版信息

Biol Pharm Bull. 2007 May;30(5):1007-10. doi: 10.1248/bpb.30.1007.

DOI:10.1248/bpb.30.1007
PMID:17473453
Abstract

The purpose of this study is to propose a kinetic model to predict the absorption of nasally applied drugs from their permeability to the Caco-2 monolayer (P(Caco-2)). Since a drug applied to the nose in an in vivo physiologic condition is translocated to the gastrointestinal (GI) tract by coordinated beats of cilia (mucociliary clearance, MC), the drug undergoes absorption both from the nasal cavity and from the GI tract. The detailed MC of the rat was examined, using inulin as a marker of the applied solution. Inulin disappeared monoexponentially from the nasal cavity, indicating that the MC can be assumed to follow first-order kinetics. From the disappearance of inulin, the first order rate constant for MC (k(MC)) was calculated as 0.0145 min(-1). In the proposed kinetic model, the fractional absorption of the drug following nasal application is predicted as the sum of F(NC) (fractional absorption from the nasal cavity) and F(GI) (fractional absorption from the GI tract), both of which are estimated indirectly from P(Caco-2). F(NC) is calculated according to the equation, k(a)/(k(a)+k(MC)), where k(a) is the absorption rate constant. Nasal drug absorption is assumed to follow first order kinetics. The k(a) of four drugs was initially calculated from k(MC) and their F(NC); thereafter, the linear relationship between k(a) and P(Caco-2), from which k(a) is predicted, was determined. F(GI) is calculated as F(p.o.)(1-F(NC)), where F(p.o.) is fractional absorption after oral administration. F(p.o.) was predicted from the previously determined sigmoid curve between F(p.o.) and P(Caco-2). The proposed kinetic model is the first estimation system for nasal drug absorption based on drug disposition after nasal application and is useful for the development of nasal dosage forms.

摘要

本研究的目的是提出一个动力学模型,以根据鼻腔给药药物对Caco-2单层细胞的渗透率(P(Caco-2))来预测其吸收情况。由于在体内生理条件下经鼻给药的药物会通过纤毛的协同摆动(黏液纤毛清除,MC)转运至胃肠道(GI),因此药物会在鼻腔和胃肠道均发生吸收。使用菊粉作为给药溶液的标志物,对大鼠的详细MC进行了研究。菊粉从鼻腔呈单指数消失,表明MC可假定遵循一级动力学。根据菊粉的消失情况,计算出MC的一级速率常数(k(MC))为0.0145 min⁻¹。在所提出的动力学模型中,鼻腔给药后药物的吸收分数预测为F(NC)(鼻腔吸收分数)和F(GI)(胃肠道吸收分数)之和,二者均根据P(Caco-2)间接估算。F(NC)根据公式k(a)/(k(a)+k(MC))计算,其中k(a)为吸收速率常数。假定鼻腔药物吸收遵循一级动力学。最初根据k(MC)及其F(NC)计算了四种药物的k(a);此后,确定了k(a)与P(Caco-2)之间的线性关系,据此可预测k(a)。F(GI)计算为F(口服)(1 - F(NC)),其中F(口服)为口服给药后的吸收分数。F(口服)根据先前确定的F(口服)与P(Caco-2)之间的S形曲线进行预测。所提出的动力学模型是首个基于鼻腔给药后药物处置情况的鼻腔药物吸收估算系统,对鼻腔剂型的开发具有重要意义。

相似文献

1
Kinetic model to predict the absorption of nasally applied drugs from in vitro transcellular permeability of drugs.用于根据药物的体外跨细胞通透性预测鼻腔给药药物吸收的动力学模型。
Biol Pharm Bull. 2007 May;30(5):1007-10. doi: 10.1248/bpb.30.1007.
2
Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.鼻腔给药后大鼠鼻腔和胃肠道对药物吸收贡献的评估。
Biol Pharm Bull. 2007 Mar;30(3):608-11. doi: 10.1248/bpb.30.608.
3
[Development of Prediction System for Drug Absorption after Intranasal Administration Incorporating Physiologic Functions of Nose -Estimation of in Vivo Drug Permeation through Nasal Mucosa Using in Vitro Membrane Permeability].[结合鼻腔生理功能的鼻内给药后药物吸收预测系统的开发——利用体外膜通透性估计体内药物经鼻黏膜的渗透]
Yakugaku Zasshi. 2021;141(11):1235-1240. doi: 10.1248/yakushi.21-00151.
4
Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).使用吸收-处置模型从Caco-2通透性估算人体药物口服吸收动力学:模型开发、评估以及ka和Fa的解析解推导
J Pharmacol Exp Ther. 2005 Jul;314(1):391-9. doi: 10.1124/jpet.104.076182. Epub 2005 Apr 15.
5
The relationship between in vivo nasal drug clearance and in vitro nasal mucociliary clearance: Application to the prediction of nasal drug absorption.体内鼻腔药物清除率与体外鼻黏膜纤毛清除率的关系:在预测鼻腔药物吸收中的应用。
Eur J Pharm Sci. 2018 May 30;117:21-26. doi: 10.1016/j.ejps.2018.01.032. Epub 2018 Feb 2.
6
Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats.采用 Calu-3 细胞单层体外膜透过率定量估算药物经鼻腔黏膜渗透,以预测大鼠经鼻给药后的体内生物利用度。
Eur J Pharm Biopharm. 2020 Apr;149:145-153. doi: 10.1016/j.ejpb.2020.02.004. Epub 2020 Feb 11.
7
Quantitative Estimation of the Effect of Nasal Mucociliary Function on in Vivo Absorption of Norfloxacin after Intranasal Administration to Rats.定量评估鼻黏液纤毛功能对大鼠鼻腔给药后体内诺氟沙星吸收的影响。
Mol Pharm. 2018 Oct 1;15(10):4462-4469. doi: 10.1021/acs.molpharmaceut.8b00464. Epub 2018 Sep 17.
8
In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.在药物产品开发中的胃肠道药物吸收的计算预测:机制吸收模型 GI-Sim 的应用。
Eur J Pharm Sci. 2013 Jul 16;49(4):679-98. doi: 10.1016/j.ejps.2013.05.019. Epub 2013 May 29.
9
An in vitro system for prediction of oral absorption of relatively water-soluble drugs and ester prodrugs.一种用于预测相对水溶性药物和酯前药口服吸收的体外系统。
Int J Pharm. 2003 Sep 16;263(1-2):35-44. doi: 10.1016/s0378-5173(03)00343-0.
10
Predicting human drug pharmacokinetics from in vitro permeability using an absorption-disposition model.使用吸收-处置模型从体外通透性预测人体药物药代动力学。
J Pharm Sci. 2007 Aug;96(8):2161-70. doi: 10.1002/jps.20866.

引用本文的文献

1
Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients.氮卓斯汀鼻喷雾剂对COVID-19患者严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒载量及相关症状影响的药代动力学建模
Pharmaceutics. 2022 Sep 27;14(10):2059. doi: 10.3390/pharmaceutics14102059.
2
Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review.经鼻腔递纳米粒子靶向神经炎症治疗神经疾病:全面综述。
Naunyn Schmiedebergs Arch Pharmacol. 2022 Feb;395(2):133-148. doi: 10.1007/s00210-021-02196-x. Epub 2022 Jan 4.
3
Evaluation of the Pharmacokinetics of Intranasal Drug Delivery for Targeting Cervical Lymph Nodes in Rats.
大鼠经鼻给药靶向颈淋巴结的药代动力学评价
Pharmaceutics. 2021 Aug 30;13(9):1363. doi: 10.3390/pharmaceutics13091363.
4
Determination and prediction of permeability across intestinal epithelial cell monolayer of a diverse range of industrial chemicals/drugs for estimation of oral absorption as a putative marker of hepatotoxicity.测定和预测多种工业化学品/药物跨肠上皮细胞单层的通透性,以评估口服吸收情况,作为肝毒性的一种推定标志物。
Toxicol Rep. 2020 Jan 14;7:149-154. doi: 10.1016/j.toxrep.2020.01.004. eCollection 2020.
5
Comparison of Various Cell Lines and Three-Dimensional Mucociliary Tissue Model Systems to Estimate Drug Permeability Using an In Vitro Transport Study to Predict Nasal Drug Absorption in Rats.使用体外转运研究比较各种细胞系和三维黏液纤毛组织模型系统以评估药物渗透性,从而预测大鼠鼻腔药物吸收情况
Pharmaceutics. 2020 Jan 17;12(1):79. doi: 10.3390/pharmaceutics12010079.
6
Improved Intranasal Retentivity and Transnasal Absorption Enhancement by PEGylated Poly-l-ornithine.聚乙二醇化聚-L-鸟氨酸改善鼻内滞留性并增强经鼻吸收
Pharmaceuticals (Basel). 2018 Jan 25;11(1):9. doi: 10.3390/ph11010009.